Stay updated on Safety of Iptacopan in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Safety of Iptacopan in IgA Nephropathy Clinical Trial page.

Latest updates to the Safety of Iptacopan in IgA Nephropathy Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.5.3 has been added to the Study Record Versions, updating the history from v3.5.2.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check21 days agoChange DetectedRevision: v3.5.2 has been added to the history. Revision: v3.5.0 has been removed.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check49 days agoChange DetectedRevision: v3.5.0 was added and v3.4.3 was removed on the page. This reflects a platform version update without changes to the study record data.SummaryDifference0.1%

- Check56 days agoChange DetectedThe history now shows a new revision entry v3.4.3 and removes the previous revision v3.4.2.SummaryDifference0.1%

- Check71 days agoChange DetectedOn 2026-02-23, Contacts/Locations and Study Status were added to the record history, and a deletion occurred on 2026-01-29.SummaryDifference0.5%

- Check85 days agoChange DetectedA new revision entry (v3.4.2) was added to the history, and a funding/operating status notice (and the older v3.4.1 entry) were removed. These are administrative updates to the revision history and do not affect study data or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

Stay in the know with updates to Safety of Iptacopan in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Iptacopan in IgA Nephropathy Clinical Trial page.